Search research articles
Contact Us
Filters
Showing results (221-230 of 273) with videos related to
Page
of 28
Sort By:
Blood Neoplasia
|
December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W Merryman, Justin Kline, Robert A Redd, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 31, 2024
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
Julie R Brahmer, Georgina V Long, Omid Hamid, et al.
Blood
|
September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
Blood Advances
|
July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma
Nira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
American Journal of Hematology
|
August 29, 2019
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
Irene M Ghobrial, Chia-Jen Liu, Oksana Zavidij, et al.
Blood Advances
|
December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Reid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.
Blood
|
December 17, 2015
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Abraham S Kanate, Alberto Mussetti, Mohamed A Kharfan-Dabaja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 273) with videos related to
Sort By:
Page
of 28
Blood Neoplasia
|
December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W Merryman, Justin Kline, Robert A Redd, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 31, 2024
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
Julie R Brahmer, Georgina V Long, Omid Hamid, et al.
Blood
|
September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
Blood Advances
|
July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma
Nira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
American Journal of Hematology
|
August 29, 2019
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
Irene M Ghobrial, Chia-Jen Liu, Oksana Zavidij, et al.
Blood Advances
|
December 3, 2025
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop
Reid W Merryman, Sarah C Rutherford, Stephen M Ansell, et al.
Blood
|
December 17, 2015
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Abraham S Kanate, Alberto Mussetti, Mohamed A Kharfan-Dabaja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Page
of 28